Antineo has a bank of 90 human cell lines and 30 murine cell lines.
They can be used for in vivo preclinical experimentation after implantation in immunosuppressed mice (CDX) or immunocompetent mice (syngeneic models), but also for in vitro experimentation.
Antineo has also developed a very original and quite unique offer of tumour models made resistant to immunotherapies.